All News

Previous studies found breastfeeding does not impact executive function or memory, which was similar to the findings in this study, according to the authors.

An interim analysis from the phase 3 ALPINE trial comparing zanubrutinib against ibrutinib demonstrated positive results in the treatment of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Further, while there is ambiguity surrounding the treatment of IBD flare in patients with CDI, case reports suggest corticosteroid initiation after appropriate antibiotic therapy may be effective.

The COVID-19 pandemic has been linked to a 44% increase in insomnia disorder among health care workers at a medical-school affiliated health system, according to a study published in the Journal of Clinical Sleep Medicine.

More and more of pharmacists and pharmacy students are staking their ground on social media.

Due to the success of its COVID-19 vaccination clinics hosted at sites such as churches and community centers across the country, Walgreens announced that it will now activate mobile clinics in Chicago, Illinois.

Although many patients are hesitant about the COVID-19 vaccines, Humphreys said pharmacists are perfectly positioned to provide education.

Interactive case studies from April 2021.

The approval of dapagliflozin is the most significant advancement in the treatment of chronic kidney disease in more than 20 years, according to a press release.

Caroline Carney, MD, MSc, FAPM, CPHQ, chief medical officer of Magellan Health, a board-certified internist, and a board-certified psychiatrist, discusses the correlation between heart health and mental health.

The necessary push for the health care industry to move to whole-person care instead of condition-oriented models and tactics for applying a value-based model in pharmacy benefits.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

High demands on the health care system from COVID-19 may mean a permanent shift in the landscape.

The FDA hold was announced in December 2020 following the diagnosis of one patient with hepatocellular carcinoma in the HOPE-B pivotal trial.

Twenty percent of the pharmacies contacted indicated they would not dispense buprenorphine, with independent pharmacies and those in southern US states found significantly more likely to restrict the drug.

A heart rhythm disorder, atrial fibrillation occurs at least twice as frequently in patients with diabetes as those without.

This product is a higher dosage of naloxone hydrochloride than the 2 mg and 4 mg dosage products previously approved by the FDA.

COVID-19 vaccines used these messenger molecules, and the future possibilities are exciting.

In this issue of Pharmacy Careers®, we highlight stories of pandemic resilience across the pharmacy landscape.

Scott J. Knoer, MS, PharmD, FASHP, EVP and CEO of APhA, discussed the value of the pharmacist on patient care teams and how this value could be supported and enhanced in the future.

The response to COVID-19 has elucidated the challenges and opportunities with pharmacy-provided services delivery.

Although the CDC and FDA have lifted the pause on Johnson & Johnson’s COVID-19 vaccine, Humphreys said the vaccine now comes with a warning label, and ongoing safety reviews will be paramount to ensure its continued safety.

Study finds that cannabidiol (CBD) and expectancies for receiving CBD do not appear to reduce experimental pain intensity but do make the pain feel less unpleasant.

Kenneth Komorny, PharmD, BCPS, a co-lead on development of National Comprehensive Cancer Network recommendations for biosimilar management, explains some of the positions the NCCN has taken.

Health care practitioners and manufacturers must change practice patterns and management strategies.

If gut-imprinted immune cells are diluted in comparison to immune cells triggered by other parts of the body, there could be implications for the oral-based COVID-19 vaccines currently under development.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Medication should be considered for patients with slightly elevated blood pressure who do not respond to 6 months of healthy lifestyle changes, according to a new statement from the American Heart Association (AHA) published in Hypertension.